FDA Inspection 554861 — Ther-RX Corporation

Ther-RX Corporation — FEI 3004839832

The FDA completed an inspection of Ther-RX Corporation on Feb 2, 2009 in Chesterfield, MO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Feb 2, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Chesterfield, MO (United States)